AMYRA BIOTECH
AMYRA is developing therapeutic product applications for the treatment of celiac disease and gluten sensitivity, which represent major public health issues. Both conditions are triggered by the ingestion of gluten in genetically predisposed people. Gluten is ubiquitously present in the Western diet and thus almost impossible to avoid.
AMYRA BIOTECH
Social Links:
Industry:
Biotechnology
Founded:
2013-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.amyra.com
Total Employee:
1+
Status:
Active
Contact:
+41 61 515 07 70
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset
Similar Organizations
![]()
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
GeneProof
GeneProof offers a wide range of in vitro molecular diagnostic products, primarily focused on the infectious diseases and genetic mutations.
![]()
MYR GmbH
MYR is a biotechnology company developing and commercilizing therapeutics for the treatment of chronic hepatitis B and D infections.
TripleMed
TripleMed aims to develop innovative and cost-effective solutions for the treatment of aortic aneurysms.
Current Employees Featured
Founder
Official Site Inspections
http://www.amyra.com Semrush global rank: 11.83 M Semrush visits lastest month: 143
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "AMYRA Biotech"
AMYRA Biotech - Crunchbase Company Profile
AMYRA is developing therapeutic product applications for the treatment of celiac disease and gluten sensitivity, which represent major public health issues. …See details»
AMYRA Biotech AG - LinkedIn
AMYRA Biotech AG is a leader in the development of innovative solutions to support and enhance the digestive capabilities of enzymes lining the small intestine. AMYRA’s Brush Border Enzyme ...See details»
AMYRA Biotech AG – Swiss Biotech
AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues. ... Type of …See details»
AMYRA Biotech 2025 Company Profile: Valuation, …
AMYRA Biotech General Information Description. Provider of therapeutic product applications intended for the treatment of celiac disease and gluten sensitivity. The company develops a highly promising, novel, enzyme-based treatment for …See details»
AMYRA Biotech AG | Top 10 Biotech Solution Company …
AMYRA Biotech AG is a Swiss based, privately held biotech company that develops a highly promising, novel, enzyme-based treatment for celiac disease (gluten intolerance) with high probability of clinical, regulatory and commercial …See details»
Imprint - Amyra Biotech
Nov 22, 2023 Amyra Biotech AG AG Malzgasse 9, 4052 Basel Switzerland Email: [email protected] Phone number: +41 61 515 0770 VAT ID: CHE-321.956.288 MWST. 1. …See details»
AMYRA Biotech AG Overview | SignalHire Company Profile
AMYRA Biotech AG is a Swiss based, privately held biotech company that develops novel, enzyme-based treatments for celiac disease and non-celiac gluten sensitivity. ... Organization …See details»
AMYRA Biotech AG - VentureRadar
AMYRA’s products consist of two recombinant exopeptidases that degrade gluten-derived, digestion resistant gluten immunogenic peptides (GIPs) into non-harmful, non-immunogenic …See details»
Amyra & Company Inc. | Canada Corporation Directory
Mar 5, 2025 Amyra & Company Inc. is located at 3000 Dumaurier Ave Ottawa ON K2B 8J1 Canada. It was registered on 19-Feb-2025, the corporation's bn is 714853629RC0001 and …See details»
Amyra Biotech - Craft
Amyra Biotech is a company that provides drug development for non-celiac gluten sensitivity and celiac diseases. It offers dietary supplements, prescription drugs, and immunological test …See details»
AMYRA Biotech - Contacts, Employees, Board Members
AMYRA is developing therapeutic product applications for the treatment of celiac disease and gluten sensitivity. ... Experience the new Crunchbase, powered by AI . Organization. AMYRA …See details»
Amyra Holdings Incorporated - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Amyra Holdings Incorporated of Brampton, ON. Get the latest business insights from Dun & Bradstreet.See details»
AMYRA Biotech AG - Solutions/Service Company
Check out this recent interview with Werner Tschollar, Founder, CEO and President and Julian Tschollar, Executive Assistant and Head of Special Projects & Silvia Tietz, Director of …See details»
AMYRA
WITNESS, Amyra’s debut album, is an experimental soul record that serves as a hymn and a battlecry, an ode to the Harlem that raised her. She has performed everywhere from the back …See details»
Amyra Biotech AG - startup.ch
Amyra Biotech AG : AMYRA is developing therapeutic product applications for the treatment of celiac disease and gluten sensitivity, which represent major public health issues. Both …See details»
AMYRA Biotech AG - Drug pipelines, Patents, Clinical trials - Synapse
AMYRA’s lead exopeptidase combination, AMYNOPEP, is capable of digesting proline-rich, hard-to-digest peptides found in foods such as gluten, which is notoriously linked to gastrointestinal …See details»
AMYRA Biotech AG -H1
The story of AMYRA Biotech AG may soon belong to this inventory Of successes—a company that is at the forefront Of developing safe and effective treatments for gluten-related disorders. …See details»
AMYRA Biotech—Solutions for gluten-related disorders
A huge medical need” said Tschollar. “AMYRA’s products target the trigger of gluten-related dis-orders and promise to provide safe and effective treatments that can improve the quality of life …See details»
Amyra Group
Amyra Group is a leader in the installation of solar water heaters and solar power plants across India. We are committed to providing sustainable energy solutions that reduce your electricity …See details»